Clinical Trials on Platinum-resistant Recurrent Ovarian Cancer in Belgium
Total 228 results
-
Mersana TherapeuticsIQVIA Biotech; PSI CRORecruitingPlatinum Resistant Ovarian Cancer | Non Small Cell Lung Cancer MetastaticUnited States, Spain, United Kingdom, Australia, France, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, Hungary, Italy, Lithuania, New Zealand, Norway, Poland, Sweden
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... and other collaboratorsCompletedRecurrent Platinum-sensitive Ovarian CancerFrance, Belgium, Germany, Australia, United Kingdom, Austria
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
Mateon TherapeuticsTerminatedPlatinum Resistant Ovarian CancerUnited States, Belgium, Germany
-
Aprea TherapeuticsCompletedPlatinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53United States, France, Spain, Netherlands, United Kingdom, Belgium, Germany, Sweden
-
Corcept TherapeuticsActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States, Belgium, Canada, Italy, Spain
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
-
SanofiCompletedOvarian Cancer RecurrentBelgium, Russian Federation, Poland, Spain, Czech Republic, United States, France, Germany, Italy, Ukraine
-
University Hospital, GhentCompletedRe-irradiation in Recurrent and Second Primary Head and Neck CancerBelgium
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
Aravive, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedPlatinum-resistant Ovarian CancerUnited States, Spain, Belgium, Canada, Georgia, Czechia, China, Poland, France, United Kingdom, Italy
-
Eisai Inc.CompletedPlatinum-Sensitive Ovarian Cancer in First RelapseUnited States, Italy, United Kingdom, Germany, Spain, Belgium, Japan
-
AGO Research GmbHHoffmann-La RocheActive, not recruitingRecurrent Ovarian CarcinomaNorway, Spain, France, Switzerland, Denmark, Germany, Sweden, Belgium, Finland, Austria, Estonia, Lithuania
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
Grupo Español de Investigación en Cáncer de OvarioGlaxoSmithKline; Hoffmann-La Roche; Apices Soluciones S.L.; AGO Study Group; ARCAGY... and other collaboratorsActive, not recruitingRecurrent Ovarian CarcinomaFrance, Spain, Belgium, Italy, Germany
-
ARCAGY/ GINECO GROUPMerck Sharp & Dohme LLC; OSE ImmunotherapeuticsRecruitingRelapsed Ovarian Cancer | Platinum-sensitive Ovarian CancerBelgium, France, Germany
-
Universitaire Ziekenhuizen KU LeuvenAstraZenecaActive, not recruitingOvarian Epithelial CancerBelgium
-
University Hospital, GhentCentre Hospitalier Universitaire Vaudois; University Ghent; Hopital Lariboisière and other collaboratorsCompletedBreast Cancer Stage IV | Peritoneal Carcinomatosis | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV | Breast Cancer Stage IIIB | Breast Cancer Stage IIIc | Ovarian Cancer Stage IIIB | Stomach Cancer Stage III | Stomach Cancer Stage IV With Metastases | Pancreas Cancer, Stage III | Pancreas Cancer, Stage...Belgium
-
Catharina Ziekenhuis EindhovenRecruitingRecurrent Rectal CancerNetherlands, Sweden, Belgium, Norway, Portugal
-
Hoffmann-La RocheCompletedColorectal Cancer, Ovarian CancerBelgium, Spain, United Kingdom
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
Sun Pharma Advanced Research Company LimitedCompletedRecurrent or Metastatic Breast CancerIndia
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
UNICANCERActive, not recruitingOvarian Epithelial Cancer RecurrentFrance, Belgium, Spain
-
Universitaire Ziekenhuizen KU LeuvenUZ Leuven, Leuven, Belgium; Policlinico Universitario A. Gemelli, IRCSS, Rome... and other collaboratorsRecruitingCervical Cancer | Ovarian Neoplasms | Ovarian Cancer | Metastatic Cancer | Pelvic Cancer | Endometrial Cancer | Ovarian Carcinoma | Uterus Cancer | Sarcoma UterusBelgium, Czechia, Italy, Sweden
-
Jules Bordet InstituteCompletedOvarian Carcinoma | RelapseBelgium
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Belgium, Czechia, Germany
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
Jules Bordet InstituteCompletedOvarian Cancer | Peritoneal CarcinomatosisBelgium
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
AmgenCompletedCancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast CancerUnited States, Belgium, France
-
Medical University InnsbruckEuropean CommissionTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerFrance, Austria, Belgium, Germany
-
Universitaire Ziekenhuizen KU LeuvenCompletedOvarian Cancer | Peritoneal MetastasisBelgium
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Germany, Belgium, Czechia
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
University Hospital, GhentRecruiting
-
Universitaire Ziekenhuizen KU LeuvenTerminated
-
Cristal TherapeuticsCompletedCancer | Ovarian CancerNetherlands, Belgium, United Kingdom
-
Clavis PharmaCompletedOvarian CancerBelgium, Italy
-
AmgenCompletedCarcinoma | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerBelgium, Spain, Australia
-
Universitaire Ziekenhuizen KU LeuvenCompletedObesity | Metabolic Syndrome | PCOSBelgium
-
University Hospital, GhentCompletedOvarian Cancer | Primary Peritoneal CancerBelgium
-
AmgenCompletedLocally Recurrent and Metastatic Breast CancerUnited States, United Kingdom, Denmark, Poland, Belgium, Hungary, Spain, Austria, France, Australia, Netherlands, Finland, India
-
University Hospital, GhentCompletedProstatic Neoplasms | Physical Activity | Exercise | Castration-resistant Prostate CancerBelgium
-
Medical University of ViennaCompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Belgium, Czechia, Denmark, Germany, Ireland, Netherlands, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Oligometastasis | Oligometastatic Disease | Hormone Sensitive Prostate CancerBelgium
-
Modra PharmaceuticalsCompletedMetastatic Breast Cancer | Recurrent Breast CancerDenmark, Belgium, Spain